HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.

Abstract
12-lipoxygenase (12-LO) was implicated in the development of diabetic nephropathy (DN), in which the proteinuria was thought to be associated with a decreased expression of glomerular P-cadherin. Therefore, we investigated the role of 12-LO in the glomerular P-cadherin expression in type 2 diabetic rats according to the glomerular sizes. Rats fed with high-fat diet for 6 wk were treated with low-dose streptozotocin. Once diabetes onset, diabetic rats were treated with 12-LO inhibitor cinnamyl-3,4-dihydroxy-cyanocinnamate (CDC) for 8 wk. Then glomeruli were isolated from diabetic and control rats with a sieving method. RT-PCR, Western blotting, and immunofluorescent staining were used for mRNA and protein expressions of P-cadherin and angiotensin II (Ang II) type 1 receptor (AT1). We found that CDC did not affect the glucose levels but completely attenuated diabetic increases in glomerular volume and proteinuria. Diabetes significantly decreased the P-cadherin mRNA and protein expressions and increased the AT1 mRNA and protein expressions in the glomeruli. These changes were significantly prevented by CDC and recaptured by direct infusion of 12-LO product [12(S)-HETE] to normal rats for 7 days. The decreased P-cadherin expression was similar between large and small glomeruli, but the increased AT1 expression was significantly higher in the large than in the small glomeruli from diabetic and 12(S)-HETE-treated rats. Direct infusion of normal rats with Ang II for 14 days also significantly decreased the glomerular P-cadherin expression. These results suggest that diabetic proteinuria is mediated by the activation of 12-LO pathway that is partially attributed to the decreased glomerular P-cadherin expression.
AuthorsQiao-Yan Guo, Li-Ning Miao, Bing Li, Fu-Zhe Ma, Nian Liu, Lu Cai, Zhong-Gao Xu
JournalAmerican journal of physiology. Endocrinology and metabolism (Am J Physiol Endocrinol Metab) Vol. 300 Issue 4 Pg. E708-16 (Apr 2011) ISSN: 1522-1555 [Electronic] United States
PMID21285403 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cadherins
  • Hydroxyeicosatetraenoic Acids
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Streptozocin
  • Arachidonate 12-Lipoxygenase
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Arachidonate 12-Lipoxygenase (genetics, metabolism, physiology)
  • Cadherins (genetics, metabolism)
  • Diabetes Mellitus, Experimental (chemically induced, genetics, metabolism, pathology)
  • Diabetes Mellitus, Type 2 (complications, genetics, metabolism, pathology)
  • Down-Regulation (drug effects)
  • Gene Expression Regulation (drug effects)
  • Hydroxyeicosatetraenoic Acids (pharmacology)
  • Kidney Glomerulus (drug effects, metabolism, pathology)
  • Male
  • Organ Size (genetics, physiology)
  • Proteinuria (etiology)
  • Rats
  • Rats, Wistar
  • Receptor, Angiotensin, Type 1 (genetics, metabolism)
  • Streptozocin
  • Up-Regulation (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: